Asia Pacific Biosimilars Market Size, Share, Forecast, and Growth Opportunity
Asia Pacific biosimilars market will grow by 30.7% annually with a total addressable market cap of $140.4 billion over 2021-2030 owing to the affordability of biosimilar-based treatment, rising incidence of chronic diseases due to aging populations, patent expirations of many blockbuster drugs, and better healthcare provisions.Highlighted with 33 tables and 56 figures, this 116-page report … Read more